Coronary artery disease (CAD) is a significant source of morbidity and mortality in
developed countries. The landmark Surgical Treatment for Ischemic Heart Failure (STICH) …

OBJECTIVES: The rationale and design of the Surgical Treatment for Ischemic Heart Failure
trial is described. Before the Surgical Treatment for Ischemic Heart Failure trial, less than …

The Surgical Treatment for Ischemic Heart Failure (STICH) trial addressed the broader role
of surgical revascularization in patients with heart failure due to reduced LV systolic function …

Revascularization and ventricular restoration in patients wi... : Current Opinion in Cardiology
Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH …

The Surgical Treatment for Ischemic Heart Failure (STICH) trial was a National Institutes of
Health (NIH)-sponsored trial investigating the relative efficacy of medical vs surgical therapy …

If the Surgical Treatment of Ischemic Heart Failure (STICH) trial demonstrates that surgical
therapy is superior to medical therapy, early aggressive evaluation of coronary artery …

The best treatment for patients with ischemic heart failure (HF) is still on debate. There is
growing evidence that coronary artery bypass graft (CABG) benefits these patients. The …

Objective There are no prospective randomized trial data to guide decisions on optimal
revascularization strategies for patients with multivessel coronary artery disease and …

The STICH trial was designed to compare coronary bypass (CABG) alone vs. CABG plus
surgical ventricular reconstruction (SVR) in patients with left ventricular (LV) dysfunction and …

Background: Patients with ischemic left ventricular dysfunction have higher operative risk
with coronary artery bypass graft surgery (CABG). However, those whose early risk is …